** Shares of Apollo Hospitals APLH.NS gain 5.4% for the
week, and set for their best week since March
** Stock top weekly pct gainer on benchmark Nifty 50 .NSEI
which is down 0.7% for the week
** The stock closed up 6.55% on Thursday, its best session
in 3 months, a day after its Q2 results beat expectations
** JP Morgan analysts say Apollo's planned expansion over
next 3 years to boost EBITDA by 14% in hospital segment, hikes
PT to 8,300 rupees from 7,200 rupees
** Apollo is "focusing on the right areas" and thus
delivering growth and profitability - Jefferies
** Tight marketing spends should lead to EBITDA break-even
for 24/7 pharmacy, Ambit Capital analysts say
** 13 analysts hiked PT on APLH since Q2 results, median PT
now at 7,827.50 vs 7,320 last month - LSEG
** APLH and rivals Max Healthcare MAXE.NS and Fortis
Healthcare FOHE.NS rated "buy" - LSEG
** APLH's 30% YTD climb greater than FOHE's 48% but smaller
than MAXE's 59% gain
(Reporting by Kashish Tandon in Bengaluru)
((Kashish.tandon@thomsonreuters.com))